Petros Pharmaceuticals Ownership 2024 | Who Owns Petros Pharmaceuticals Now?

Overview RevenueFinancials Chart

Institutional Ownership

3.35%

Insider Ownership

8.44%

Retail Ownership

88.21%

Institutional Holders

13.00

Petros Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	0.80%	-	16,510	3	0.02%	23,031,000	Mar 31, 2023
VANGUARD GROUP INC	0.53%	-	10,889	-8,902	-44.98%	15,190,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.11%	0.00%	2,310	1,807	359.24%	3,000	Mar 31, 2023
EMFO, LLC	0.05%	0.00%	1,000	-	-	1,395,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	17	-	-	24,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	14	14	100.00%	20,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	14	12	600.00%	19,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	10	-	-	14,000	Mar 31, 2023
FIRST MANHATTAN CO. LLC.	0.00%	-	10	-	-	13,000	Mar 31, 2023
UBS GROUP AG	-	-	-	-1,098	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-200	-100.00%	-	Mar 31, 2023

Petros Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 0.80% of the company's total share outstanding, currently valued at $23.03M. The top 10 institutional shareholders own together 1.49% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
EMFO, LLC	0.05%	0.00%	1,000	-	-	1,395,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.11%	0.00%	2,310	1,807	359.24%	3,000	Mar 31, 2023
BLACKROCK INC.	0.80%	-	16,510	3	0.02%	23,031,000	Mar 31, 2023
VANGUARD GROUP INC	0.53%	-	10,889	-8,902	-44.98%	15,190,000	Mar 31, 2023
FIRST MANHATTAN CO. LLC.	0.00%	-	10	-	-	13,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	14	14	100.00%	20,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	10	-	-	14,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	17	-	-	24,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	14	12	600.00%	19,000	Mar 31, 2023
UBS GROUP AG	-	-	-	-1,098	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-200	-100.00%	-	Mar 31, 2023

The largest Petros Pharmaceuticals shareholder by % of total assets is EMFO, LLC. The company owns 1.00K shares of Petros Pharmaceuticals (PTPI), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TOWER RESEARCH CAPITAL LLC (TRC)	0.11%	0.00%	2,310	1,807	359.24%	3,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	14	14	100.00%	20,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	14	12	600.00%	19,000	Mar 31, 2023
BLACKROCK INC.	0.80%	-	16,510	3	0.02%	23,031,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	17	-	-	24,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	10	-	-	14,000	Mar 31, 2023
FIRST MANHATTAN CO. LLC.	0.00%	-	10	-	-	13,000	Mar 31, 2023
EMFO, LLC	0.05%	0.00%	1,000	-	-	1,395,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-200	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-1,098	-100.00%	-	Mar 31, 2023
VANGUARD GROUP INC	0.53%	-	10,889	-8,902	-44.98%	15,190,000	Mar 31, 2023

As of Mar 31 2023, Petros Pharmaceuticals's largest institutional buyer is TOWER RESEARCH CAPITAL LLC (TRC). The company purchased 1.81K stocks of PTPI, valued at $3.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	0.53%	-	10,889	-8,902	-44.98%	15,190,000	Mar 31, 2023
UBS GROUP AG	-	-	-	-1,098	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-200	-100.00%	-	Mar 31, 2023
EMFO, LLC	0.05%	0.00%	1,000	-	-	1,395,000	Mar 31, 2023
FIRST MANHATTAN CO. LLC.	0.00%	-	10	-	-	13,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	10	-	-	14,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	17	-	-	24,000	Mar 31, 2023
BLACKROCK INC.	0.80%	-	16,510	3	0.02%	23,031,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	14	12	600.00%	19,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	14	14	100.00%	20,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.11%	0.00%	2,310	1,807	359.24%	3,000	Mar 31, 2023

As of Mar 31 2023, Petros Pharmaceuticals's biggest institutional seller is VANGUARD GROUP INC. The company sold -8.90K shares of PTPI, valued at $15.19M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	14	14	100.00%	20,000	Mar 31, 2023

Petros Pharmaceuticals's largest new institutional shareholder by number of shares is ADVISOR GROUP HOLDINGS, INC., purchased 14.00 shares, valued at $20.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	-	-	-	-1,098	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-200	-100.00%	-	Mar 31, 2023

Petros Pharmaceuticals's largest sold out institutional shareholder by shares sold is UBS GROUP AG, sold -1.10K shares, valued at -, as of undefined.

Petros Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	255,914	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	69,023	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	31,811	-31,811	-50.00%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	9,957	-	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	972	-	-	Jan 31, 2024
iSHARES TRUST	0.00%	25,321	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	1,299	-	-	Mar 31, 2024

Petros Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 255.91K shares, compromising 0.00% of its total assets.

Petros Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 22	13	-7.14%
30 Jun, 22	14	-26.32%
31 Mar, 22	19	-9.52%
31 Dec, 21	21	40.00%
30 Sep, 21	15	-16.67%
30 Jun, 21	18	5.88%
31 Mar, 21	17	-15.00%
31 Dec, 20	20	-

As of 30 Sep 22, 13 institutions are holding Petros Pharmaceuticals's shares, representing a decrease of -7.14% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 22	693,567	3.04%
30 Jun, 22	673,120	-19.27%
31 Mar, 22	833,814	-22.46%
31 Dec, 21	1,075,312	32.37%
30 Sep, 21	812,328	-15.67%
30 Jun, 21	963,310	-15.24%
31 Mar, 21	1,136,521	28.30%
31 Dec, 20	885,862	-

Petros Pharmaceuticals (PTPI) has 693.57K shares outstanding as of 30 Sep 22, up 3.04% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 22	3.35%	31.65%
30 Jun, 22	3.25%	20.03%
31 Mar, 22	4.03%	4.13%
31 Dec, 21	9.87%	17.74%
30 Sep, 21	7.46%	9.53%
30 Jun, 21	8.85%	8.12%
31 Mar, 21	10.44%	15.77%
31 Dec, 20	8.13%	-

As of 30 Sep 22, Petros Pharmaceuticals is held by 3.35% institutional shareholders, representing a 31.65% growth compared to 30 Jun 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 22	4	-33.33%
30 Jun, 22	6	-40.00%
31 Mar, 22	10	-33.33%
31 Dec, 21	15	400.00%
30 Sep, 21	3	-70.00%
30 Jun, 21	10	25.00%
31 Mar, 21	8	-60.00%
31 Dec, 20	20	-

4 institutional shareholders have increased their position in PTPI stock as of 30 Sep 22 compared to 6 in the previous quarter (a -33.33% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 22	1	-50.00%
30 Jun, 22	2	-
31 Mar, 22	2	-33.33%
31 Dec, 21	3	-40.00%
30 Sep, 21	5	-
30 Jun, 21	5	150.00%
31 Mar, 21	2	-
31 Dec, 20	-	-

1 institutional shareholders have reduced their position in PTPI stock as of 30 Sep 22 compared to 2 in the previous quarter (a -50.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 22	13	-7.14%	693,567	3.04%	3.35%	31.65%	4	-33.33%	1	-50.00%
30 Jun, 22	14	-26.32%	673,120	-19.27%	3.25%	20.03%	6	-40.00%	2	-
31 Mar, 22	19	-9.52%	833,814	-22.46%	4.03%	4.13%	10	-33.33%	2	-33.33%
31 Dec, 21	21	40.00%	1,075,312	32.37%	9.87%	17.74%	15	400.00%	3	-40.00%
30 Sep, 21	15	-16.67%	812,328	-15.67%	7.46%	9.53%	3	-70.00%	5	-
30 Jun, 21	18	5.88%	963,310	-15.24%	8.85%	8.12%	10	25.00%	5	150.00%
31 Mar, 21	17	-15.00%	1,136,521	28.30%	10.44%	15.77%	8	-60.00%	2	-
31 Dec, 20	20	-	885,862	-	8.13%	-	20	-	-	-

Petros Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 28, 2023	Bradley Greg	director	-	M-Exempt	Sell	6,050	-	-	-
Apr 28, 2023	Bernstein Bruce	director	-	M-Exempt	Sell	6,050	-	-	-
Apr 28, 2023	WALKER WAYNE REMELL	director	-	M-Exempt	Sell	6,050	-	-	-
Apr 28, 2023	Silverman Joshua	director	-	M-Exempt	Sell	6,722	-	-	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 26, 2023	Bernstein Bruce	director	-	A-Award	Buy	40,000	$1.41	$56.40K	40,000
Dec 26, 2023	Boctor Fady	officer	See Remarks	A-Award	Buy	54,533	$1.41	$76.89K	54,533
Dec 26, 2023	Boctor Fady	officer	See Remarks	A-Award	Buy	49,645	-	-	49,645
Dec 26, 2023	WALKER WAYNE REMELL	director	-	A-Award	Buy	40,000	$1.41	$56.40K	40,000
Dec 26, 2023	Arnold Mitchell	officer	See Remarks	A-Award	Buy	20,000	$1.41	$28.20K	20,000
Dec 26, 2023	Silverman Joshua	director	-	A-Award	Buy	40,000	$1.41	$56.40K	40,000
Dec 26, 2023	Bradley Greg	director	-	A-Award	Buy	40,000	$1.41	$56.40K	40,000
Apr 28, 2023	Bradley Greg	director	-	M-Exempt	Buy	6,050	-	-	8,314
Apr 28, 2023	Bradley Greg	director	-	M-Exempt	Sell	6,050	-	-	-
Apr 28, 2023	Bernstein Bruce	director	-	M-Exempt	Buy	6,050	-	-	8,346
Apr 28, 2023	Bernstein Bruce	director	-	M-Exempt	Sell	6,050	-	-	-
Apr 28, 2023	WALKER WAYNE REMELL	director	-	M-Exempt	Buy	6,050	-	-	8,314
Apr 28, 2023	WALKER WAYNE REMELL	director	-	M-Exempt	Sell	6,050	-	-	-
Apr 28, 2023	Silverman Joshua	director	-	M-Exempt	Buy	6,722	-	-	11,237
Apr 28, 2023	Silverman Joshua	director	-	M-Exempt	Sell	6,722	-	-	-
Apr 12, 2023	WALKER WAYNE REMELL	director	-	A-Award	Buy	39,000	$0.99	$38.61K	39,000
Apr 12, 2023	Silverman Joshua	director	-	A-Award	Buy	39,000	$0.99	$38.61K	39,000
Apr 12, 2023	Bradley Greg	director	-	A-Award	Buy	39,000	$0.99	$38.61K	39,000
Apr 12, 2023	Bernstein Bruce	director	-	A-Award	Buy	39,000	$0.99	$38.61K	39,000
Jan 25, 2023	WALKER WAYNE REMELL	director	-	M-Exempt	Buy	2,264	-	-	2,264

The last insider sell of Petros Pharmaceuticals's stock was made by Bradley Greg on Apr 28 2023, selling 6,050 shares at - per share (valued at -).

Petros Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	8	4	200.00%
Q1 2023	4	4	100.00%
Q2 2022	4	-	-
Q4 2021	10	-	-
Q2 2021	7	-	-
Q1 2021	1	-	-
Q4 2020	14	9	155.56%
Q1 2020	-	1	-

8 total buy trades, and 4 total sell trades (buy/sell ratio of 2.00%) were made by Petros Pharmaceuticals's insiders, as of Q2 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	-	-	-
Q1 2023	-	-	-
Q2 2022	-	-	-
Q4 2021	6	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q4 2020	-	-	-
Q1 2020	-	-	-

As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Petros Pharmaceuticals's stocks.

Petros Pharmaceuticals Peer Ownership

Ticker	Company
SNOA	Sonoma Pharmaceuticals, Inc.
AKAN	Akanda Corp.
EVOK	Evoke Pharma, Inc.
TKNO	Alpha Teknova, Inc.
SBFM	Sunshine Biopharma, Inc.
LFCR	Lifecore Biomedical, Inc.
GHSI	Guardion Health Sciences, Inc.
ALIM	Alimera Sciences, Inc.
SHPH	Shuttle Pharmaceuticals Holdings, Inc.
CPIX	Cumberland Pharmaceuticals Inc.
ADMP	Adamis Pharmaceuticals Corporation
LSDI	Lucy Scientific Discovery Inc.
PRFX	PainReform Ltd.
AGRX	Agile Therapeutics, Inc.
SXTC	China SXT Pharmaceuticals, Inc.

PTPI Ownership FAQ

Who Owns Petros Pharmaceuticals?

Petros Pharmaceuticals is owned by institutional shareholders (3.35%), insiders (8.44%), and public (88.21%). The largest institutional shareholder of Petros Pharmaceuticals is BLACKROCK INC. (0.80% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Petros Pharmaceuticals?

Petros Pharmaceuticals's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, TOWER RESEARCH CAPITAL LLC (TRC), EMFO, LLC, and MORGAN STANLEY. The top five shareholders own together 1.48% of the company's share outstanding.

How many Petros Pharmaceuticals shareholders are there?

As of Sep 2022, there are 13 institutional shareholders of Petros Pharmaceuticals.

What percentage of Petros Pharmaceuticals is owned by BLACKROCK INC?

BLACKROCK INC owns 16.51K shares of Petros Pharmaceuticals, representing 0.80% of the company's total shares outstanding, valued at $23.03M (as of Mar 2023).

What percentage of Petros Pharmaceuticals is owned by VANGUARD GROUP INC?

As of Mar 2023, VANGUARD GROUP INC holds 10.89K shares of Petros Pharmaceuticals (PTPI), compromising 0.53% of the company, valued at $15.19M.

What percentage of Petros Pharmaceuticals is owned by TOWER RESEARCH CAPITAL LLC (TRC)?

TOWER RESEARCH CAPITAL LLC (TRC) is the third largest holder of Petros Pharmaceuticals. The company owns 2.31K of the company's shares outstanding (worth $3K).